Invivyd (IVVD) Receivables (2023 - 2025)

Invivyd (IVVD) posted Receivables of $14.6 million for Q4 2025, up 44.02% on a QoQ basis from $10.1 million in Q3 2025, and up 30.67% year-over-year from $11.2 million in Q4 2024.

Invivyd (IVVD) Receivables (2023 - 2025) Analysis & Trends

Invivyd's Receivables history runs 3 years deep, the most recent figure standing at $14.6 million for Q4 2025.

  • Quarterly Receivables rose 30.67% year-over-year to $14.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.6 million (up 30.67% YoY) and the FY2025 annual result came in at $14.6 million, up 30.67% from the prior year.
  • Receivables was $14.6 million for Q4 2025 at Invivyd, up from $10.1 million in the prior quarter.
  • Across five years, Receivables topped out at $14.6 million in Q4 2025 and bottomed at $933000.0 in Q4 2023.
  • A 3-year average of $8.3 million and a median of $8.8 million in 2025 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2024 — Receivables jumped 1097.11% — and 2025, when it increased 17.02%.
  • Invivyd's Receivables stood at $933000.0 in 2023, then soared by 1097.11% to $11.2 million in 2024, then soared by 30.67% to $14.6 million in 2025.
  • Business Quant data shows IVVD's Receivables at $14.6 million in Q4 2025, $10.1 million in Q3 2025, and $8.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 4.97 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 938.02 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.93 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Invivyd 104.07 Mn -122.62 Mn 16.07 Mn 14.60 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 14.60 Mn
Sep 30, 2025 10.13 Mn
Jun 30, 2025 8.81 Mn
Mar 31, 2025 8.75 Mn
Dec 31, 2024 11.17 Mn
Sep 30, 2024 8.66 Mn
Jun 30, 2024 3.54 Mn
Dec 31, 2023 933,000.00